SEC Charges Former Trial Statistician with Insider Trading

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

SEC Charges Former Trial Statistician with Insider Trading

J.W. Schomisch

July 12, 2023 at 12:35 PM EST

The Securities and Exchange Commission (SEC) charged a former Pfizer Inc. employee with insider trading for trading in advance of a company announcement regarding results of a clinical trial (Securities and Exchange Commission v. Dagar, No. 1:23-cv-05564 (S.D.N.Y.)). According to the SEC, on the day before Pfizer announced the results of its randomized, double-blind study of ... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

SEC Charges Former Trial Statistician with Insider Trading

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT